Thanks for sharing. Interesting points about possible further partnering this year and that IMM are now just trying to consolidate feedback from EMA and FDA on the phase 3 trial. The comments on reaching manufacturing scale up opens the door for commercial options.
Marc also mentioned that the TACTI first line NSCLC results will be presented 'at a conference' this half. So from the website, presumably this will be at ASCO 2022 (3-7 June)
Media, page-168
-
- There are more pages in this discussion • 215 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.005(1.56%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.8¢ | 31.0¢ | $1.817M | 5.763M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 71665 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 36363 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |